Diagnostics (Apr 2023)

A Patient with Synchronous Gallbladder and Bone Plasmacytoma

  • Mariam Markouli,
  • Alexia Saridaki,
  • Nora-Athina Viniou,
  • Nefeli Giannakopoulou,
  • Eleftheria Lakiotaki,
  • Penelope Korkolopoulou,
  • Panagiotis Diamantopoulos

DOI
https://doi.org/10.3390/diagnostics13091509
Journal volume & issue
Vol. 13, no. 9
p. 1509

Abstract

Read online

Multiple myeloma (MM) is the most common primary bone-originating tumor, whereas extramedullary plasmacytoma (EMP) is a plasma cell tumor that arises outside the bone and is most commonly found in the head and neck area. Gastrointestinal and particularly gallbladder involvement is exceedingly rare, and symptoms, if any are present, are usually similar to those seen with cholelithiasis. Treatment options usually include surgical resection and/or chemotherapy. In this report, we present a rare case of a clinically unexpected plasmablastic extramedullary plasmacytoma that was found on abdominal ultrasound (US) and magnetic resonance imaging (MRI) in a 61-year-old asymptomatic patient and led him to undergo cholecystectomy. A fluorodeoxyglucose positron emission computed tomography (FDG PET-CT) that was performed due to the onset of left thigh pain also demonstrated concurrent bone plasmacytoma. The patient is currently receiving chemotherapy and is also being prepared for autologous stem cell transplantation. In this context, we further present the diagnostic, therapeutic and prognostic challenges of EMPs. Lastly, we point out the distinct features of the plasmablastic subtype and analyze its differences compared to other histologic subtypes in achieving a successful diagnosis and management.

Keywords